Anika Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Anika Therapeutics, Inc. (ANIK) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $248.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2024-11-04
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $248.00K.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $300.00K.
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $316.00K.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $127.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2024-09-30 | $248.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $300.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $316.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $127.00K 10-K · filed 2024-03-15 |
| 2023-09-30 | $10.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $188.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $632.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.05M 10-K · filed 2023-03-16 |
| 2022-09-30 | $78.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $21.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $9.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $975.00K 10-K · filed 2022-03-11 |
| 2021-09-30 | $4.65M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |